HR 3240 · 106th Congress · Health

Drug Import Fairness Act of 1999

Introduced 1999-11-05· Sponsored by Rep. Gutknecht, Gil [R-MN-1]· House

Bill Progress

Introduced
Committee
House Vote
4
Senate
5
Enacted
Latest: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.(2000-06-29)

Plain Language Summary

[AI summary unavailable — showing source text] Drug Import Fairness Act of 1999 - Amends the Federal Food, Drug, and Cosmetic Act (FDCA) to prohibit the Secretary of Health and Human Services, with regard to a drug being imported or offered for import, from sending a notice to a person suggesting that importing the drug is, or appears to be, in violation of the FDCA unless: (1) the Secretary determines the drug is adulterated, misbranded, in violation of FDCA provisions relating to new drugs, the drug is forbidden or restricted in sale in the producing or exporting country, importation by any person other than the manufacturer violates reimportation provisions, or the importation otherwise violates Federal law; (2) the notice does not specify any provision described in the provisions of this act relating to those determinations that is not applicable to the drug's importation; and (3) the notice states the underlying reasons for the determination.…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (20)

5 Democrats15 Republicans